This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Boric, M. P. Articles by Croxatto, H. R. Search for Related Content PubMed PubMed Citation Articles by Boric, M. P. Articles by Croxatto, H. R.

(Hypertension. 1995;26:1167-1172.)
© 1995 American Heart Association, Inc.

Articles

Inhibition of Atrial Natriuretic Peptide Excretory Action by Bradykinin

Mauricio P. Boric; Héctor R. Croxatto

From the Unidad de Regulación Neurohumoral, Departamento de Ciencias Fisiológicas, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile.

Correspondence to Mauricio P. Boric, PhD, Departamento Ciencias Fisiológicas, FCCBB, Pontificia Universidad Católica de Chile, Casilla 114-D, Santiago, Chile. E-mail mboric@genes.bio.puc.cl.

Abstract We examined whether the excretory effect of atrial natriuretic peptide could be antagonized by intravenously administered bradykinin or by elevated endogenous kinin levels attained during converting enzyme inhibition. Urinary volume and sodium and potassium excretion were determined every 20 minutes in female, anesthetized Sprague-Dawley rats (weight, 0.19 to 0.22 kg) infused with 10 µL/min isotonic glucose. In some experiments, urinary cGMP content was measured by radioimmunoassay. Two intravenous boluses of 209 pmol (0.5 µg) atrial natriuretic peptide were given before and after the injection of test substances, and the response ratio was used to quantify inhibition. Single injections of 94.3 or 142 pmol (100 or 150 ng) bradykinin, 3 minutes prior to atrial natriuretic peptide, inhibited the excretion of water, sodium, and potassium by 70%, 75%, and 50%, respectively. Larger (236 to 472 pmol) or smaller (23.6 to 47.2 pmol) bradykinin doses were ineffective. None of the bradykinin doses tested affected basal urinary output, systemic pressure, or the modest depressor effect of atrial natriuretic peptide. The anti–atrial natriuretic peptide effect of bradykinin was completely prevented by the kinin receptor antagonist Hoe 140. Converting enzyme inhibition with ramipril (96 nmol IV) also blunted atrial natriuretic peptide diuresis and natriuresis by 70% and reduced urinary cGMP excretion by 50%. These effects of ramipril were mediated by endogenous kinin accumulation, since they were abolished by pretreatment with Hoe 140. It is concluded that intrarenal kinins modulate the renal actions of atrial natriuretic peptide, and at a precise concentration bradykinin strongly antagonizes atrial natriuretic peptide by preventing its transduction mechanism.

Key Words: atrial natriuretic factor • ramipril • ACE • kinins • cyclic GMP

This article has been cited by other articles:

				J. C. Casar, A. Valdivieso, J. A. Bravo, C. Chacón, and M. P. Boric Reduced Natriuresis After Oral Sodium Load in Cholestatic Rats: Role of Compartment Volumes and ANP Experimental Biology and Medicine, October 1, 2000; 225(1): 23 - 31. [Abstract] [Full Text]

				H. R. Croxatto, X. F. Figueroa, J. Roblero, and M. P. Boric Kinin B2 Receptors Mediate Blockade of Atrial Natriuretic Peptide Natriuresis Induced by Glucose or Feeding in Fasted Rats Hypertension, October 1, 1999; 34(4): 826 - 831. [Abstract] [Full Text] [PDF]

				M. P. Boric, X. F. Figueroa, M. V. Donoso, A. Paredes, I. Poblete, and J. P. Huidobro-Toro Rise in endothelium-derived NO after stimulation of rat perivascular sympathetic mesenteric nerves Am J Physiol Heart Circ Physiol, September 1, 1999; 277(3): H1027 - H1035. [Abstract] [Full Text] [PDF]